William Blair Initiates Coverage on Structure Therapeutics (NASDAQ:GPCR)
William Blair started coverage on shares of Structure Therapeutics (NASDAQ:GPCR – Free Report) in a research note published on Friday, Marketbeat Ratings reports. The brokerage issued an outperform rating on the stock. GPCR has been the topic of several other reports. JMP Securities reiterated a “market outperform” rating and issued a $91.00 target price on […]
William Blair started coverage on shares of Structure Therapeutics (NASDAQ:GPCR – Free Report) in a research note published on Friday, Marketbeat Ratings reports. The brokerage issued an outperform rating on the stock. GPCR has been the topic of several other reports. JMP Securities reiterated a “market outperform” rating and issued a $91.00 target price on […]
